Adopting and Sustaining a Cervical Precancer Treatment in El Salvador
Official title: Evaluating the adoption, implementation, and maintenance of a cervical precancer treatment in El Salvador
Funded at Cleveland Clinic Lerner Com-Cwru · NIH-11535383 · Data updated 2026-11-12
This project explores how a low-resource setting can implement and keep using a cervical precancer treatment to help women in El Salvador.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project start | September 11, 2025 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $18,652 |
| NIH project number | 3R21CA293274-02S1 |
| Project ID | NIH-11535383 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women in El Salvador or similar resource-poor settings who are diagnosed with cervical precancer and eligible for thermal ablation.
✕Less likely to help
Patients in contexts without resource limitations or those not receiving cervical precancer treatment may derive little direct benefit.
What this research studies
In settings with limited resources, we want to understand what helps or hinders putting a proven cervical precancer treatment into routine care. The study looks at how clinicians, patients, and health systems adopt, implement, and maintain thermal ablation as a point-of-care option, and how it can be sustained over time. By examining real-world experiences in El Salvador, the project aims to identify practical strategies that could improve access and outcomes for women at risk of cervical cancer. The findings should inform policymakers and clinics on scalable approaches to implement effective treatment where resources are constrained.
Why it matters
Potential benefit: If successful, the work could guide better implementation of cervical precancer treatment in low-resource settings, improving access and outcomes for women at risk of cervical cancer.
How similar studies have gone: Previous work has shown that understanding local implementation factors can improve adoption and sustainability of EBIs in varied settings, but data on cervical precancer treatments in low-resource environments remain limited.
Where this research is happening
-
Cleveland Clinic Lerner Com-Cwru
Cleveland, United States Active
Researchers
- Principal investigator: Soler, Montserrat — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Soler, Montserrat
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.